SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NIO

NIO Inc. (New York Stock Exchange:NIO)

CN · Delayed Price · Currency is USD
Also listed: 0A1K.L, N3IA.FConsumer Cyclical · Auto - Manufacturers
3.26-0.03 (-0.91%)
 
Market cap
$7.85B
Health Score
Analyst consensus
Listed since
Sep 12, 2018
Website
Insider Score
––Not scored
NIO Insider Score

Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

NIO analyst forecast

NIO analyst consensus

Hold2 ratings
Buy 0 Hold 2 Sell 0

Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.

NIO 12-month price target

$5.55+70.3% upsideaverage of 2 firms
$6.10High
$5.00Low

Best analysts covering NIO

  • Citigroup33%success rate · 6 calls
  • Barclays20%success rate · 5 calls
  • Goldman Sachs0%success rate · 3 calls
  • HSBC0%success rate · 2 calls

Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.

NIO analyst ratings

FirmPrice targetAction
Goldman Sachs—$6.10+58.0%—2026-09-04
—JP MorganNeutral——Downgraded2026-09-02
BernsteinMarket Perform$5.00+23.3%Reiterated2026-09-02
—Goldman SachsBuy——Upgraded2026-07-13
—HSBCBuy——Upgraded2026-03-13
—BarclaysUnderweight——Reiterated2025-11-28
—Freedom Capital MarketsBuy——Upgraded2025-11-28
—Freedom BrokerBuy——Upgraded2025-11-28
—CitigroupBuy——Reiterated2025-11-26
—MacquarieNeutral——Downgraded2025-11-26
—MizuhoNeutral——Reiterated2025-09-23
—UBSBuy——Upgraded2025-09-16
—Freedom Capital MarketsHold——Downgraded2025-09-04
—B of A SecuritiesNeutral——Reiterated2025-09-03
—MizuhoNeutral——Reiterated2025-09-03
—JP MorganOverweight——Upgraded2025-08-26
—JP MorganNeutral——Reiterated2025-08-14
—Goldman SachsNeutral——Upgraded2025-06-17
—BarclaysUnderweight——Reiterated2025-06-04
—MizuhoNeutral——Reiterated2025-06-03
—MizuhoNeutral——Reiterated2025-05-16
—Goldman SachsSell——Reiterated2025-04-24
—MizuhoNeutral——Reiterated2025-04-10
—CitigroupBuy——Reiterated2025-03-24
—MizuhoNeutral——Reiterated2025-03-24
—JP MorganNeutral——Downgraded2025-02-04
—Goldman SachsSell——Reiterated2025-01-21
—Goldman SachsSell——Downgraded2024-11-25
—MacquarieNeutral——Downgraded2024-11-20
—MacquarieOutperform——Upgraded2024-10-28
—JP MorganOverweight——Upgraded2024-09-06
—B of A SecuritiesNeutral——Reiterated2024-09-05
—CitigroupBuy——Reiterated2024-09-04
—B of A SecuritiesNeutral——Reiterated2024-06-07
—CitigroupBuy——Reiterated2024-06-06
—B of A SecuritiesNeutral——Reiterated2024-05-28
—JP MorganNeutral——Upgraded2024-05-15
—BarclaysUnderweight——Downgraded2024-04-02
—MizuhoNeutral——Downgraded2024-03-25
—UBSNeutral——Reiterated2024-03-14
—HSBCBuy——Reiterated2024-03-12
—Morgan StanleyOverweight——Reiterated2024-03-11
—BernsteinMarket Perform——Reiterated2024-03-07
—JP MorganUnderweight——Reiterated2024-03-06
—B of A SecuritiesNeutral——Reiterated2024-03-06
—BarclaysEqual Weight——Reiterated2024-03-06
—JefferiesHold——Reiterated2024-03-06
—JP MorganUnderweight——Downgraded2024-02-23
—B of A SecuritiesNeutral——Downgraded2024-01-09
—MizuhoBuy——Reiterated2023-12-06
—Deutsche BankBuy——Reiterated2023-09-06
—MizuhoBuy——Reiterated2023-08-30
—BernsteinMarket Perform——Reiterated2023-08-30
—JP MorganNeutral——Reiterated2023-08-30
—B of A SecuritiesBuy——Reiterated2023-08-30
—Deutsche BankBuy——Reiterated2023-08-11
—UBSNeutral——Reiterated2023-07-31
—JP MorganNeutral——Reiterated2023-07-21
—Morgan StanleyOverweight——Reiterated2023-07-05
—BarclaysEqual Weight——Reiterated2023-06-13

NIO earnings vs. estimates

QuarterEPS est.EPS actualRevenue est.Revenue actual
2026-03-10-0.050.01$4.77B$4.95B
2026-05-21-0.08-0.03$3.69B$3.70B
2026-09-01-0.07-0.04$4.79B$4.73B
2026-11-24-0.030.00$4.93B$0
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.